Genebass resource linking protein-coding variants to health and disease
“Genebass [sic] is a resource of exome-based association statistics, made available to [MORE]
Ben Shen microbial collection assembled by Pfizer
For nearly a century, the pharmaceutical company collected microorganisms of potential drug value. Now [MORE]
Liver Cancer Care
Earlier this year, Pfizer, Eli Lilly, and Merck agreed to create a nonprofit Asian Cancer Research Group [MORE]
Drug-maker Pfizer (New York City) has engaged the social networking company, Private Access (Irvine, CA) to create what the partners [MORE]
Researchers at the Imperial College, London and their commercial spin-out, DNA Electronics, have devised a handheld instrument that does a [MORE]
Solianis Monitoring AG (Zurich, Switzerland) has recently completed a study of its wearable, noninvasive, multisensor glucose monitor that tracks blood [MORE]
Pfizer believes that its highest payoff for R&D will be in oncology, pain, inflammation, diabetes, Alzheimer’s’ disease and [MORE]